Gland Pharma Limited has informed the Exchange about Schedule of meet
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gland Pharma has informed the stock exchanges about an upcoming group meeting with analysts and institutional investors arranged by Goldman Sachs, scheduled for March 5, 2026. The disclosure has been made under SEBI's Listing Obligations and Disclosure Requirements Regulations (Regulation 30) to keep the market informed of the company's investor engagement schedule. The filing notes that the meeting schedule is subject to change due to unforeseen circumstances on the part of the investor, analyst, or the company. No specific agenda, financial details, or material information has been shared in this intimation.
This is a routine compliance filing and is unlikely to have any direct impact on the stock price. Investors should watch for any follow-up disclosures after the meeting, as material information shared during such interactions is sometimes disseminated separately as price-sensitive updates.